Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV

Published:2022-11-22 Issue:3 Volume:37 Page:455-465
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Jagi Jaya Laxmi,Thomas Christy,Gudi Sai Krishna,Undela Krishna

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference39 articles.

1. Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis;Lahey;Clin Infect Dis,2013

2. Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India;Kapoor;Int J Tuberc Lung Dis,2016

3. Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in Eritrea;Russom;Pharmacol Res Perspect,2018

4. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources;Lawn;Lancet Infect Dis,2010

5. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children;Madhi;N Engl J Med,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes;The International Journal of Tuberculosis and Lung Disease;2023-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP